Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92.

Calero Moreno TM, Gustafsson G, Garwicz S, Grandér D, Jonmundsson GK, Frost BM, Mäkipernaa A, Rasool O, Savolainen ER, Schmiegelow K, Söderhäll S, Vettenranta K, Wesenberg F, Einhorn S, Heyman M.

Leukemia. 2002 Oct;16(10):2037-45.

2.

Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc.

Scarpa A, Moore PS, Rigaud G, Inghirami G, Montresor M, Menegazzi M, Todeschini G, Menestrina F.

Br J Haematol. 1999 Oct;107(1):106-13.

PMID:
10520030
3.

Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions.

Diccianni MB, Batova A, Yu J, Vu T, Pullen J, Amylon M, Pollock BH, Yu AL.

Leuk Res. 1997 Jun;21(6):549-58.

PMID:
9279366
4.

Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.

Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JW, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, et al.

Blood. 1995 Jul 15;86(2):755-60.

PMID:
7606004

Supplemental Content

Loading ...
Support Center